chr11-95838183-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016156.6(MTMR2):​c.1504G>C​(p.Glu502Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0273 in 1,605,020 control chromosomes in the GnomAD database, including 1,053 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 158 hom., cov: 32)
Exomes 𝑓: 0.026 ( 895 hom. )

Consequence

MTMR2
NM_016156.6 missense

Scores

5
8
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:8

Conservation

PhyloP100: 6.09
Variant links:
Genes affected
MTMR2 (HGNC:7450): (myotubularin related protein 2) This gene is a member of the myotubularin family of phosphoinositide lipid phosphatases. The encoded protein possesses phosphatase activity towards phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4B, an autosomal recessive demyelinating neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067712367).
BP6
Variant 11-95838183-C-G is Benign according to our data. Variant chr11-95838183-C-G is described in ClinVar as [Benign]. Clinvar id is 306538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-95838183-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0804 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTMR2NM_016156.6 linkc.1504G>C p.Glu502Gln missense_variant Exon 13 of 15 ENST00000346299.10 NP_057240.3 Q13614-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTMR2ENST00000346299.10 linkc.1504G>C p.Glu502Gln missense_variant Exon 13 of 15 1 NM_016156.6 ENSP00000345752.6 Q13614-1

Frequencies

GnomAD3 genomes
AF:
0.0369
AC:
5613
AN:
151980
Hom.:
159
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0568
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0173
Gnomad ASJ
AF:
0.0179
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0876
Gnomad FIN
AF:
0.0764
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0236
Gnomad OTH
AF:
0.0375
GnomAD3 exomes
AF:
0.0348
AC:
8712
AN:
250530
Hom.:
285
AF XY:
0.0379
AC XY:
5132
AN XY:
135374
show subpopulations
Gnomad AFR exome
AF:
0.0541
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.0166
Gnomad EAS exome
AF:
0.000761
Gnomad SAS exome
AF:
0.0903
Gnomad FIN exome
AF:
0.0801
Gnomad NFE exome
AF:
0.0231
Gnomad OTH exome
AF:
0.0337
GnomAD4 exome
AF:
0.0262
AC:
38127
AN:
1452924
Hom.:
895
Cov.:
29
AF XY:
0.0285
AC XY:
20649
AN XY:
723270
show subpopulations
Gnomad4 AFR exome
AF:
0.0571
Gnomad4 AMR exome
AF:
0.0111
Gnomad4 ASJ exome
AF:
0.0168
Gnomad4 EAS exome
AF:
0.000530
Gnomad4 SAS exome
AF:
0.0902
Gnomad4 FIN exome
AF:
0.0758
Gnomad4 NFE exome
AF:
0.0194
Gnomad4 OTH exome
AF:
0.0278
GnomAD4 genome
AF:
0.0369
AC:
5610
AN:
152096
Hom.:
158
Cov.:
32
AF XY:
0.0398
AC XY:
2956
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.0567
Gnomad4 AMR
AF:
0.0173
Gnomad4 ASJ
AF:
0.0179
Gnomad4 EAS
AF:
0.000964
Gnomad4 SAS
AF:
0.0872
Gnomad4 FIN
AF:
0.0764
Gnomad4 NFE
AF:
0.0236
Gnomad4 OTH
AF:
0.0366
Alfa
AF:
0.0236
Hom.:
47
Bravo
AF:
0.0312
TwinsUK
AF:
0.0191
AC:
71
ALSPAC
AF:
0.0215
AC:
83
ESP6500AA
AF:
0.0561
AC:
247
ESP6500EA
AF:
0.0212
AC:
182
ExAC
AF:
0.0360
AC:
4375
Asia WGS
AF:
0.0350
AC:
121
AN:
3478
EpiCase
AF:
0.0254
EpiControl
AF:
0.0250

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 4B1 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 02, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 10, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1Benign:1
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Inherited Neuropathy Consortium
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: literature only

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease type 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.60
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.87
D;.;.;.;D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.97
D;D;.;.;D
MetaRNN
Benign
0.0068
T;T;T;T;T
MetaSVM
Uncertain
-0.041
T
MutationAssessor
Uncertain
2.9
M;.;.;.;.
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-2.9
D;D;D;D;D
REVEL
Pathogenic
0.69
Sift
Benign
0.092
T;T;T;T;T
Sift4G
Benign
0.11
T;T;T;T;.
Polyphen
0.66
P;.;.;.;.
Vest4
0.30
MPC
0.43
ClinPred
0.037
T
GERP RS
4.6
Varity_R
0.69
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61735578; hg19: chr11-95571347; API